These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33007133)

  • 1. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
    Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
    Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
    Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
    Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
    Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
    Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
    Zhou S; da Silva SD; Siegel PM; Philip A
    Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
    Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
    Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
    Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis.
    Liu XX; Feng AP; He YM; Li Y; Wu Y; Lian X; Hu F; Li JW; Tu YT; Chen SJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):132-136. PubMed ID: 26838754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
    Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
    Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.
    Mori N; Esaki N; Shimoyama Y; Shiraki Y; Asai N; Sakai T; Nishida Y; Takahashi M; Enomoto A; Mii S
    Pathol Res Pract; 2023 May; 245():154443. PubMed ID: 37030166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling.
    Naoi H; Suzuki Y; Miyagi A; Horiguchi R; Aono Y; Inoue Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Mii S; Ichihara M; Takahashi M; Suda T
    J Immunol; 2024 Apr; 212(7):1221-1231. PubMed ID: 38334455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
    Man XY; Finnson KW; Baron M; Philip A
    Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
    Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
    Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.
    Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S
    Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.
    Zhang F; Lin H; Gu A; Li J; Liu L; Yu T; Cui Y; Deng W; Yan M; Li J; Yao M
    J Proteomics; 2014 May; 102():125-36. PubMed ID: 24667143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
    Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
    Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses.
    Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A
    Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
    Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
    Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer.
    Adachi K; Sakurai Y; Ichinoe M; Tadehara M; Tamaki A; Kesen Y; Kato T; Mii S; Enomoto A; Takahashi M; Koizumi W; Murakumo Y
    Virchows Arch; 2022 Apr; 480(4):819-829. PubMed ID: 34762199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
    Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
    Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.